Hennessy Advisors Inc Amgen Inc Transaction History

Hennessy Advisors Inc

$3.05 Billion
Q3 2024

A detailed history of Hennessy Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, Hennessy Advisors Inc holds 13,100 shares of AMGN stock, worth $3.86 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

13,100

Previous 13,300 1.5%

Holding current value

$3.86 Million

Previous $4.16 Million 1.56%

% of portfolio

0.14%

Previous 0.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$309.38 - $337.38 $61,876 - $67,476	-200 Reduced 1.5%	13,100 $4.22 Million
Q2 2024 Jul 23, 2024	BUY	$262.75 - $319.31 $26,275 - $31,931	100 Added 0.76%	13,300 $4.16 Million
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $3.55 Million - $4.28 Million	13,200 New	13,200 $3.75 Million
Q4 2023 Jan 18, 2024	BUY	$255.7 - $288.46 $1.59 Million - $1.79 Million	6,200 Added 66.67%	15,500 $4.46 Million
Q3 2023 Oct 18, 2023	SELL	$218.65 - $271.46 $43,730 - $54,291	-200 Reduced 2.11%	9,300 $2.5 Million
Q2 2023 Jul 17, 2023	SELL	$214.27 - $253.37 $117,848 - $139,353	-550 Reduced 5.47%	9,500 $2.11 Million
Q1 2023 Apr 14, 2023	SELL	$225.79 - $275.2 $5.58 Million - $6.8 Million	-24,700 Reduced 71.08%	10,050 $2.43 Million
Q4 2022 Jan 20, 2023	SELL	$229.03 - $291.01 $2.29 Million - $2.91 Million	-10,000 Reduced 22.35%	34,750 $9.13 Million
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $22,446 - $25,315	100 Added 0.22%	44,750 $10.1 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $46,142 - $51,348	-200 Reduced 0.45%	44,650 $10.9 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $3.03 Million - $3.35 Million	13,800 Added 44.44%	44,850 $10.8 Million
Q4 2021 Jan 25, 2022	BUY	$198.88 - $227.6 $1.77 Million - $2.03 Million	8,900 Added 40.18%	31,050 $6.99 Million
Q3 2021 Oct 12, 2021	BUY	$212.27 - $248.7 $413,926 - $484,965	1,950 Added 9.65%	22,150 $4.71 Million
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $268,617 - $298,011	1,150 Added 6.04%	20,200 $4.92 Million
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $2.7 Million - $3.14 Million	-12,150 Reduced 38.94%	19,050 $4.74 Million
Q4 2020 Jan 25, 2021	SELL	$216.38 - $257.67 $346,208 - $412,272	-1,600 Reduced 4.88%	31,200 $7.17 Million
Q3 2020 Oct 16, 2020	SELL	$234.65 - $260.95 $164,255 - $182,665	-700 Reduced 2.09%	32,800 $8.34 Million
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $178,029 - $218,466	-900 Reduced 2.62%	33,500 $7.9 Million
Q1 2020 Apr 14, 2020	SELL	$182.24 - $241.7 $619,616 - $821,780	-3,400 Reduced 8.99%	34,400 $6.97 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $416,262 - $535,040	-2,200 Reduced 5.5%	37,800 $9.11 Million
Q3 2019 Oct 07, 2019	SELL	$174.11 - $208.62 $191,521 - $229,482	-1,100 Reduced 2.68%	40,000 $7.74 Million
Q2 2019 Jul 11, 2019	SELL	$166.7 - $195.41 $16,670 - $19,541	-100 Reduced 0.24%	41,100 $7.57 Million
Q1 2019 Apr 08, 2019	BUY	$180.87 - $203.88 $1.99 Million - $2.24 Million	11,000 Added 36.42%	41,200 $7.83 Million
Q4 2018 Jan 14, 2019	SELL	$178.4 - $208.25 $196,240 - $229,075	-1,100 Reduced 3.51%	30,200 $5.88 Million
Q1 2018 May 02, 2018	BUY	$169.43 - $198.0 $5.3 Million - $6.2 Million	31,300 New	31,300 $5.34 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennessy Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hennessy Advisors Inc with notifications on news.

Account

Hennessy Advisors Inc Amgen Inc Transaction History